Exelixis (NasdaqGS:EXEL) 2025 R&D Day Transcript

Exelixis (NasdaqGS:EXEL) 2025 R&D Day December 10, 2025 01:00 PM ET Company ParticipantsMichael M. Morrissey - President and CEODana T. Aftab - EVP of Research and DevelopmentAnwaar Saeed - Chief of GI OncologySusan Hubbard - EVP of Public Affairs and Investor RelationsP.J. Haley - EVP of CommercialJennifer Chan - Clinical Director of Gastrointestinal Cancer Treatment CenterToni Choueiri - Director of the Lank Center for Genitourinary OncologyOperatorWelcome to the Exelixis virtual event. Please welcome Exe ...